ASLAN Pharmaceuticals Information

View Top Employees from ASLAN Pharmaceuticals

ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is developing eblasakimab, a potential first-in-class antibody targeting the IL-13 receptor in moderate-to-severe atopic dermatitis, and farudodstat, a potent oral inhibitor of the enzyme DHODH, as a potential first-in-class treatment for alopecia areata. ASLAN has teams in San Mateo, California, and in Singapore. For additional information please visit www.aslanpharma.com.

Website	http://www.aslanpharma.com
Ticker	ASLN
Revenue	$9.1 million
Employees	44 (7 on RocketReach)
Founded	2010
Address	83 Clemenceau Ave #12-03 Ue Sq, Singapore, Central Singapore 239920, SG
Phone	+65 6222 4235
Fax	(656) 225-2419
Technologies	JavaScript , HTML , PHP +32 more (view full list)
Industry	Pharmaceutical Manufacturing, Pharmaceuticals, Biotechnology, Medical Equipment Manufacturing, Healthcare, Science and Engineering, Medical, Health Care, Pharmaceutical
Web Rank	3 Million
Keywords	Biopharmaceutical, Immunology, Clinical Stage, Drug Development, Antibody Therapeutics, Innovative Treatments, Patient Care, Pharmaceutical Research, Biotechnology, Therapeutics, Clinical Trials, New Drug Development, Drug Discovery, Healthcare, Medicine, Life Sciences, Biologics, Oncology, Immuno-Oncology, First-In-Class
Competitors	Roche, Bristol Myers Squibb, Novartis, Merck & Co., Inc., Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Amgen, Lilly India +47 more (view full list)
SIC	SIC Code 283 Companies, SIC Code 28 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies